MYGN·62855J104·US·equity·Healthcare - Diagnostics & Research-13D/G
MYGN (MYRIAD GENETICS INC) is held by 119 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($40M), MILLENNIUM MANAGEMENT LLC ($30M), GLENVIEW CAPITAL MANAGEMENT, LLC ($24.4M). Net institutional sentiment: Mixed.
See how MYGN's score breaks down across 4 SEC sources
Showing 1-20 of 134
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer